Lenderts Susan, Kalali Amir H, Buckley Peter
Ms. Lenderts is Manager, Strategic Analytics, Quintiles Commercial, Falls Church, Virginia.
Psychiatry (Edgmont). 2010 Mar;7(3):9-10.
In this article, we explore the penetration of generic atypical antipsychotics in the United States market before and after the availability of generic risperidone in July 2008. Analysis suggests that, overall, generic penetration into the atypical antipsychotic market has grown from approximately three percent in January 2008 to more than 25 percent in December 2009. Similar trends are uncovered when branded and generic prescriptions are analyzed by specialty.
在本文中，我们探讨了2008年7月利培酮仿制药上市前后美国市场上非典型抗精神病仿制药的渗透率。分析表明，总体而言，非典型抗精神病药物市场的仿制药渗透率已从2008年1月的约3%增长至2009年12月的超过25%。按专科分析品牌药和仿制药处方时也发现了类似趋势。
